- Home
- CAPR vs BBAI Comparison
CAPR vs BBAI Comparison
Compare CAPR & BBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- BBAI
- Stock Information
- Founded
- CAPR 2005
- BBAI 2020
- Country
- CAPR United States
- BBAI United States
- Employees
- CAPR N/A
- BBAI N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- BBAI EDP Services
- Sector
- CAPR Health Care
- BBAI Technology
- Exchange
- CAPR Nasdaq
- BBAI Nasdaq
- Market Cap
- CAPR 867.6M
- BBAI 716.7M
- IPO Year
- CAPR N/A
- BBAI N/A
- Fundamental
- Price
- CAPR $13.07
- BBAI $3.04
- Analyst Decision
- CAPR Strong Buy
- BBAI Buy
- Analyst Count
- CAPR 7
- BBAI 4
- Target Price
- CAPR $39.29
- BBAI $3.17
- AVG Volume (30 Days)
- CAPR 1.8M
- BBAI 46.2M
- Earning Date
- CAPR 11-13-2024
- BBAI 11-05-2024
- Dividend Yield
- CAPR N/A
- BBAI N/A
- EPS Growth
- CAPR N/A
- BBAI N/A
- EPS
- CAPR N/A
- BBAI N/A
- Revenue
- CAPR $23,228,045.00
- BBAI $154,972,000.00
- Revenue This Year
- CAPR N/A
- BBAI $13.47
- Revenue Next Year
- CAPR $74.85
- BBAI $16.32
- P/E Ratio
- CAPR N/A
- BBAI N/A
- Revenue Growth
- CAPR 65.33
- BBAI 0.01
- 52 Week Low
- CAPR $3.52
- BBAI $1.17
- 52 Week High
- CAPR $23.40
- BBAI $4.80
- Technical
- Relative Strength Index (RSI)
- CAPR 37.42
- BBAI 52.81
- Support Level
- CAPR $12.25
- BBAI $2.42
- Resistance Level
- CAPR $20.75
- BBAI $3.82
- Average True Range (ATR)
- CAPR 1.62
- BBAI 0.57
- MACD
- CAPR -0.24
- BBAI -0.04
- Stochastic Oscillator
- CAPR 9.65
- BBAI 27.85
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment.